Allergan (AGN) Tops Q4 EPS by 5c
Tweet
Share
E-mail
Get Alerts AGN Hot Sheet
Price: $193.02 --0%
Financial Fact:
Total non-operating income (expense): 26.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Total non-operating income (expense): 26.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Allergan (NYSE: AGN) reported Q4 EPS of $3.41, $0.05 better than the analyst estimate of $3.36. Revenue for the quarter came in at $4.2 billion versus the consensus estimate of $4.2 billion.
GUIDANCE:
Allergan sees FY2016 revenue of abot $17 billion, versus the consensus of $17.66 billion.
For earnings history and earnings-related data on Allergan (AGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
- Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
